Global Smart Inhalers Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel, By Regional Outlook and Forecast, 2021 - 2027

The Global Smart Inhalers Market size is expected to reach $414.4 million by 2027, rising at a market growth of 24.9% CAGR during the forecast period.

Smart inhalers are inhalation devices that deliver a range of medications. Inhalers contain anticholinergic, glucocorticoids, insulin, and beta-agonists, which are used to treat and prevent respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). When sensors are placed as a clip to inhalers to monitor the proper dose per intake and the technique used for inhaling the drug, these inhalers are referred to as smart inhalers. The sensor's data is shared with the patient and healthcare practitioners in order to track inhaler usage. The monitored data is then exchanged with their mobile apps via an internet platform using Bluetooth technology, and electronic health records (EHR) or electronic medical records (EMR) are preserved as a result.

Some smart inhalers have sensors that can identify whether a person is in a polluted or pollen-filled environment, give useful reminders, and indicate if an individual's inhaler technique needs to be reviewed. Individuals do not need to maintain their own records because all inhalers are intended to automatically track how often they are used.

Indoor air pollution in households in underdeveloped and developing countries is becoming a more widespread problem with an increase in the population of these countries. Respiratory problems such as COPD and asthma are more common in people who live in substandard housing and neighborhoods. Inhalation of particles occurs when kerosene lights and portable stoves are used for heating and cooking. Furthermore, rising tobacco consumption among both men and women in high-income nations, as well as increased risk of indoor air pollution, are projected to raise the prevalence of respiratory disease in both men and women. Smoking, biomass fuel for heating and cooking, and poor ventilation are all sources of indoor pollution in low-income countries. As a result, an increase in indoor pollution is expected to lead to an increase in asthma and COPD cases, driving the market.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic has impacted various sectors of the business domain. The imposition of various restrictions like lockdown, ban on cross border travelling, social distancing norm, temporary ban on manufacturing units and ban on imports & exports, have disrupted the supply chain of various goods or products across the world. In addition, the burden on healthcare sector has increased due to the pandemic. The COVID-19 pandemic is expected to have a favorable impact on the market for smart inhalers. A large number of clinics and hospitals around the world have been reconfigured to boost hospital capacity for COVID-19 patients. Due to the substantial increase in COVID-19 cases, non-essential procedures may face a backlog.

Market driving Factors:

Increase in The Incidence of Chronic Respiratory Diseases

Asthma is the name of a chronic pulmonary disease by which both children and adults can be affected. Due to inflammation and tightening of the muscles around the tiny airways, the air channels in the lungs shrink. Asthma patients suffer from symptoms such as coughing, wheezing, shortness of breath, and chest tightness. These sensations are transitional, however, importantly, these symptoms worsen at night and during physical workouts. Asthma symptoms can be exacerbated by other common external and internal factors. Viral infections (colds), dust, smoke, fumes, changes in the weather, grass and tree pollen, animal fur and feathers, harsh soaps, and perfume are all potential triggers the intensity of the effects of the triggers that may vary from person to person.

Smart Inhalers are More Efficient Than Regular Inhalers

Smart inhalers are not only simply inhalers but any electronic devices capable of sharing data and tracking records. With the use of Bluetooth, digital inhalers may be connected to smartphones, allowing for dosing reminders and dose monitoring. Additionally, these devices have patient education tools that help to reduce dosing errors, resulting in lower hospitalization and treatment costs. The number of doctor visits of patients who utilized these types of inhalers fell dramatically. Increasing research and development about smart inhalers are likely to make them more effective and efficient, thus increasing their demand in the market.

Marketing Restraining Factor:

Smart Inhalers are Expensive

A smart inhaler is priced at around $99 on average. This varies based on the brand and the capabilities it offers. Naturally, the more sophisticated the capabilities, the more expensive they are. The same may be said for the cost of smart inhalers, which have sensors built into the device. Only specific medications and inhalers are authorized for use with some smart inhalers. As a result, double-checking the manufacturer's website or asking the pharmacist for further information about the inhaler, asthma treatments, and mobile device compatibility becomes essential. Purchasing medications can be costly, and purchasing equipment or devices to help manage the disease implies further expenses.

Product Outlook

Based on Product, the market is segmented into Metered Dose Inhalers (MDI's), and Dry Powdered Inhalers (DPIs). The dry powder inhaler (DPI) segment witnessed a significant revenue share in the smart inhalers market in 2020. A dry powder inhaler (DPI), which is a handheld device, can be used to administer certain drugs in the form of a dry powder. As users inhale through it, a DPI delivers medication to their lungs. There are no propellants or other substances in it; only the medication, which is propelling the growth of the segment.

Disease Indication Outlook

Based on Disease Indication, the market is segmented into Asthma, and Chronic Obstructive Pulmonary Disease (COPD). The asthma segment garnered the largest revenue share in the smart inhalers market in 2020. This is because of the sheer growing incidence of persons suffering from asthma. During the next few years, the segmental expansion will be fueled by a growing patient pool. In the United States, for example, 1 in 13 people have asthma, according to the Centers for Disease Control and Prevention (CDC). It is estimated that over 25 million Americans suffer from asthma. As a result, the rising prevalence of asthma, combined with rising public knowledge about the disease's risk, will drive the adoption of the smart inhalers market over the forecast period. The increase in demand for smart inhalers is likely to continue to do so during the forecast period.

Distribution Channel Outlook

Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies. The retail pharmacies segment observed a significant revenue share in the smart inhalers market in 2020. The increasing number of retail pharmacies around the world is responsible for the high increase. Furthermore, numerous smart inhaler manufacturers are stepping up their attempts to form partnerships with retail pharmacies in order to begin selling these devices over-the-counter, which will help the market grow even faster. Another key factor driving growth is the increasing number of FDA approvals for over-the-counter sales of digital inhalers. Adherium, for example, received FDA approval for over-the-counter sales of their digital inhaler sensor for AstraZeneca's asthma inhalation device in April 2018.

Smart Inhalers Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 84.6 Million
Market size forecast in 2027	USD 414.4 Million
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 24.9% from 2021 to 2027
Number of Pages	205
Number of Tables	334
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Product Type, Disease Indication, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increase in The Incidence of Chronic Respiratory Diseases Smart Inhalers are More Efficient Than Regular Inhalers
Restraints	Smart Inhalers are Expensive

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The North American segment acquired the largest revenue share of the smart inhalers market in 2020. This is due to improved healthcare infrastructure and services, a higher prevalence of asthma and COPD patients, the adoption of technologically sophisticated therapies, and increased healthcare expenditure in the region. People in North America tend to be more affluent than the population of the rest of the world and thus, the increasing adoption of smart inhalers in the region has not come to anyone surprise.

Free Valuable Insights: Global Smart Inhalers Market size to reach USD 414.4 Million by 2027

KBV Cardinal Matrix - Smart Inhalers Market Competition Analysis

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Novartis AG is the forerunners in the Smart Inhalers Market. Companies such as AstraZeneca, Inc., GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Adherium Limited, Aptar Group Inc. (Cohero Health Inc.), AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health, Inc., Philip Morris International, Inc. (Vectura Group Plc), Resmed, Inc. (Propeller Health), and Teva Pharmaceutical Industries Ltd.

Recent Strategies Deployed in Smart Inhalers Market

• Feb-2022: Aptar Pharma introduced HeroTracker Sense, a novel digital respiratory health solution. The device is designed to enhance the health of patients across the world suffering from chronic respiratory diseases such as COPD, Cystic Fibrosis, asthma, and other respiratory conditions caused by COVID-19. Additionally, the device tracks their MDI usage and expedites enhanced adherence to their prescribed treatment.
• Sep-2020: Teva Respiratory introduced ArmonAir Digihaler inhalation powder and AirDuo Digihaler inhalation powder. These two digital inhalers help in managing asthma inhalers among patients.
• Jul-2020: Novartis received European Commission approval for glycopyrronium bromide, Enerzair Breezhaler, mometasone furoate, and indacaterol acetate for the treatment of asthma. Through this approval, the drugs provide precaution treatment in adult patients not appropriately controlled with a management combination of a long-acting beta2 agonist as well as a high-dose of an inhaled corticosteroid who experienced one or more asthma worsening in the previous year.
• Apr-2020: Aptar teamed up with Sonmol, a leading Chinese digital respiratory therapeutics company. Under this collaboration, the companies focused on delivering connected digital platforms and drug delivery devices for chronic obstructive pulmonary and asthma disease. Moreover, this collaboration aimed to develop digital services and therapies platforms targeting respiratory and other diseases.
• Jan-2020: Cognita Labs received the FDA approval for CapMedic, a smart inhaler cap. The device alerts patients to utilize inhalers in the right way. Additionally, Developers believe the feedback mechanism differentiates the device from other smart inhalers.
• Jan-2020: Aptar Pharma joined hands with Lupin Limited, an Indian multinational pharmaceutical company. Together, the companies aimed to introduce India’s first linked device for metered-dose inhalers called ADHERO. The smart device is developed to help patients with chronic respiratory diseases to track MDI utilization and facilitate enhanced attachment to their prescribed therapy.
• Aug-2019: Adherium came into partnership with Summatix, a medical informatics company. Under this partnership, the companies empower doctors to improve the health of patients with chronic obstructive pulmonary and asthma diseases. Additionally, the Adherium post-reconstruction business model improves its platform abilities and sensor development by approaching and collaborating with dominant development houses to focus on insights on how data, and its application, would influence the practice of medicine.
• Jul-2019: ResMed took over Propeller Health, a digital therapeutics company providing connected health solutions. Through this partnership, Propeller’s digital solutions strengthen ResMed’s large portfolio of products that can treat millions of people at multiple stages of their COPD and other chronic diseases, all aimed at enhancing people’s condition of life, while minimizing the effects of these hospitalizations, diseases, and the overall price of healthcare.
• Aug-2018: Adherium introduced the Hailie solution in the U.S. The Food and Drug Administration approved that Hailie assists COPD and asthma patients to approach better precaution through a consistent digital experience that includes a smartphone app, available on both Android and iOS, along with a sensor that adheres to the patient’s prescription inhaler medication.
• Sep-2017: Adherium received the FDA approval for clearance for its new SmartTouch for Symbicort, inhaler monitoring technology for AstraZeneca’s Symbicort aerosol inhaler. Through this approval, Symbicort equipped into patient's inhaler to monitor and boost medication adherence as part of a self-administration plan.
• Sep-2017: GlaxoSmithKline expanded its partnership with Propeller Health, a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management. Together, the companies aimed to design digital solutions for asthma and chronic obstructive pulmonary disorder.
• Jan-2017: AstraZeneca received the FDA approval for Symbicort Inhalation Aerosol 80/4.5 micrograms. The medicine is introduced for the treatment of asthma in pediatric patients from age six up to 12 years. Additionally, Symbicort's FDA approval was based on the CHASE clinical trial program, including the CHASE 3 Phase III trial.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Metered Dose Inhalers (MDI's)
• Dry Powdered Inhalers (DPIs)

By Disease Indication

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Adherium Limited
• Aptar Group Inc. (Cohero Health Inc.)
• AstraZeneca, Inc.
• Cognita Labs, LLC
• GlaxoSmithKline Plc
• Novartis AG
• OPKO Health, Inc.
• Philip Morris International, Inc. (Vectura Group Plc)
• Resmed, Inc. (Propeller Health)
• Teva Pharmaceutical Industries Ltd.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Smart Inhalers Market, by Product
1.4.2 Global Smart Inhalers Market, by Disease Indication
1.4.3 Global Smart Inhalers Market, by Distribution Channel
1.4.4 Global Smart Inhalers Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials

Chapter 4. Global Smart Inhalers Market by Product
4.1 Global Metered Dose Inhalers (MDI's) Market by Region
4.2 Global Dry Powdered Inhalers (DPIs) Market by Region

Chapter 5. Global Smart Inhalers Market by Disease Indication
5.1 Global Asthma Market by Region
5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Market by Region

Chapter 6. Global Smart Inhalers Market by Distribution Channel
6.1 Global Hospitals Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Smart Inhalers Market by Region
7.1 North America Smart Inhalers Market
7.1.1 North America Smart Inhalers Market by Product
7.1.1.1 North America Metered Dose Inhalers (MDI's) Market by Country
7.1.1.2 North America Dry Powdered Inhalers (DPIs) Market by Country
7.1.2 North America Smart Inhalers Market by Disease Indication
7.1.2.1 North America Asthma Market by Country
7.1.2.2 North America Chronic Obstructive Pulmonary Disease (COPD) Market by Country
7.1.3 North America Smart Inhalers Market by Distribution Channel
7.1.3.1 North America Hospitals Pharmacies Market by Country
7.1.3.2 North America Retail Pharmacies Market by Country
7.1.3.3 North America Online Pharmacies Market by Country
7.1.4 North America Smart Inhalers Market by Country
7.1.4.1 US Smart Inhalers Market
7.1.4.1.1 US Smart Inhalers Market by Product
7.1.4.1.2 US Smart Inhalers Market by Disease Indication
7.1.4.1.3 US Smart Inhalers Market by Distribution Channel
7.1.4.2 Canada Smart Inhalers Market
7.1.4.2.1 Canada Smart Inhalers Market by Product
7.1.4.2.2 Canada Smart Inhalers Market by Disease Indication
7.1.4.2.3 Canada Smart Inhalers Market by Distribution Channel
7.1.4.3 Mexico Smart Inhalers Market
7.1.4.3.1 Mexico Smart Inhalers Market by Product
7.1.4.3.2 Mexico Smart Inhalers Market by Disease Indication
7.1.4.3.3 Mexico Smart Inhalers Market by Distribution Channel
7.1.4.4 Rest of North America Smart Inhalers Market
7.1.4.4.1 Rest of North America Smart Inhalers Market by Product
7.1.4.4.2 Rest of North America Smart Inhalers Market by Disease Indication
7.1.4.4.3 Rest of North America Smart Inhalers Market by Distribution Channel
7.2 Europe Smart Inhalers Market
7.2.1 Europe Smart Inhalers Market by Product
7.2.1.1 Europe Metered Dose Inhalers (MDI's) Market by Country
7.2.1.2 Europe Dry Powdered Inhalers (DPIs) Market by Country
7.2.2 Europe Smart Inhalers Market by Disease Indication
7.2.2.1 Europe Asthma Market by Country
7.2.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Market by Country
7.2.3 Europe Smart Inhalers Market by Distribution Channel
7.2.3.1 Europe Hospitals Pharmacies Market by Country
7.2.3.2 Europe Retail Pharmacies Market by Country
7.2.3.3 Europe Online Pharmacies Market by Country
7.2.4 Europe Smart Inhalers Market by Country
7.2.4.1 Germany Smart Inhalers Market
7.2.4.1.1 Germany Smart Inhalers Market by Product
7.2.4.1.2 Germany Smart Inhalers Market by Disease Indication
7.2.4.1.3 Germany Smart Inhalers Market by Distribution Channel
7.2.4.2 UK Smart Inhalers Market
7.2.4.2.1 UK Smart Inhalers Market by Product
7.2.4.2.2 UK Smart Inhalers Market by Disease Indication
7.2.4.2.3 UK Smart Inhalers Market by Distribution Channel
7.2.4.3 France Smart Inhalers Market
7.2.4.3.1 France Smart Inhalers Market by Product
7.2.4.3.2 France Smart Inhalers Market by Disease Indication
7.2.4.3.3 France Smart Inhalers Market by Distribution Channel
7.2.4.4 Russia Smart Inhalers Market
7.2.4.4.1 Russia Smart Inhalers Market by Product
7.2.4.4.2 Russia Smart Inhalers Market by Disease Indication
7.2.4.4.3 Russia Smart Inhalers Market by Distribution Channel
7.2.4.5 Spain Smart Inhalers Market
7.2.4.5.1 Spain Smart Inhalers Market by Product
7.2.4.5.2 Spain Smart Inhalers Market by Disease Indication
7.2.4.5.3 Spain Smart Inhalers Market by Distribution Channel
7.2.4.6 Italy Smart Inhalers Market
7.2.4.6.1 Italy Smart Inhalers Market by Product
7.2.4.6.2 Italy Smart Inhalers Market by Disease Indication
7.2.4.6.3 Italy Smart Inhalers Market by Distribution Channel
7.2.4.7 Rest of Europe Smart Inhalers Market
7.2.4.7.1 Rest of Europe Smart Inhalers Market by Product
7.2.4.7.2 Rest of Europe Smart Inhalers Market by Disease Indication
7.2.4.7.3 Rest of Europe Smart Inhalers Market by Distribution Channel
7.3 Asia Pacific Smart Inhalers Market
7.3.1 Asia Pacific Smart Inhalers Market by Product
7.3.1.1 Asia Pacific Metered Dose Inhalers (MDI's) Market by Country
7.3.1.2 Asia Pacific Dry Powdered Inhalers (DPIs) Market by Country
7.3.2 Asia Pacific Smart Inhalers Market by Disease Indication
7.3.2.1 Asia Pacific Asthma Market by Country
7.3.2.2 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Market by Country
7.3.3 Asia Pacific Smart Inhalers Market by Distribution Channel
7.3.3.1 Asia Pacific Hospitals Pharmacies Market by Country
7.3.3.2 Asia Pacific Retail Pharmacies Market by Country
7.3.3.3 Asia Pacific Online Pharmacies Market by Country
7.3.4 Asia Pacific Smart Inhalers Market by Country
7.3.4.1 China Smart Inhalers Market
7.3.4.1.1 China Smart Inhalers Market by Product
7.3.4.1.2 China Smart Inhalers Market by Disease Indication
7.3.4.1.3 China Smart Inhalers Market by Distribution Channel
7.3.4.2 Japan Smart Inhalers Market
7.3.4.2.1 Japan Smart Inhalers Market by Product
7.3.4.2.2 Japan Smart Inhalers Market by Disease Indication
7.3.4.2.3 Japan Smart Inhalers Market by Distribution Channel
7.3.4.3 India Smart Inhalers Market
7.3.4.3.1 India Smart Inhalers Market by Product
7.3.4.3.2 India Smart Inhalers Market by Disease Indication
7.3.4.3.3 India Smart Inhalers Market by Distribution Channel
7.3.4.4 South Korea Smart Inhalers Market
7.3.4.4.1 South Korea Smart Inhalers Market by Product
7.3.4.4.2 South Korea Smart Inhalers Market by Disease Indication
7.3.4.4.3 South Korea Smart Inhalers Market by Distribution Channel
7.3.4.5 Singapore Smart Inhalers Market
7.3.4.5.1 Singapore Smart Inhalers Market by Product
7.3.4.5.2 Singapore Smart Inhalers Market by Disease Indication
7.3.4.5.3 Singapore Smart Inhalers Market by Distribution Channel
7.3.4.6 Malaysia Smart Inhalers Market
7.3.4.6.1 Malaysia Smart Inhalers Market by Product
7.3.4.6.2 Malaysia Smart Inhalers Market by Disease Indication
7.3.4.6.3 Malaysia Smart Inhalers Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Smart Inhalers Market
7.3.4.7.1 Rest of Asia Pacific Smart Inhalers Market by Product
7.3.4.7.2 Rest of Asia Pacific Smart Inhalers Market by Disease Indication
7.3.4.7.3 Rest of Asia Pacific Smart Inhalers Market by Distribution Channel
7.4 LAMEA Smart Inhalers Market
7.4.1 LAMEA Smart Inhalers Market by Product
7.4.1.1 LAMEA Metered Dose Inhalers (MDI's) Market by Country
7.4.1.2 LAMEA Dry Powdered Inhalers (DPIs) Market by Country
7.4.2 LAMEA Smart Inhalers Market by Disease Indication
7.4.2.1 LAMEA Asthma Market by Country
7.4.2.2 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Market by Country
7.4.3 LAMEA Smart Inhalers Market by Distribution Channel
7.4.3.1 LAMEA Hospitals Pharmacies Market by Country
7.4.3.2 LAMEA Retail Pharmacies Market by Country
7.4.3.3 LAMEA Online Pharmacies Market by Country
7.4.4 LAMEA Smart Inhalers Market by Country
7.4.4.1 Brazil Smart Inhalers Market
7.4.4.1.1 Brazil Smart Inhalers Market by Product
7.4.4.1.2 Brazil Smart Inhalers Market by Disease Indication
7.4.4.1.3 Brazil Smart Inhalers Market by Distribution Channel
7.4.4.2 Argentina Smart Inhalers Market
7.4.4.2.1 Argentina Smart Inhalers Market by Product
7.4.4.2.2 Argentina Smart Inhalers Market by Disease Indication
7.4.4.2.3 Argentina Smart Inhalers Market by Distribution Channel
7.4.4.3 UAE Smart Inhalers Market
7.4.4.3.1 UAE Smart Inhalers Market by Product
7.4.4.3.2 UAE Smart Inhalers Market by Disease Indication
7.4.4.3.3 UAE Smart Inhalers Market by Distribution Channel
7.4.4.4 Saudi Arabia Smart Inhalers Market
7.4.4.4.1 Saudi Arabia Smart Inhalers Market by Product
7.4.4.4.2 Saudi Arabia Smart Inhalers Market by Disease Indication
7.4.4.4.3 Saudi Arabia Smart Inhalers Market by Distribution Channel
7.4.4.5 South Africa Smart Inhalers Market
7.4.4.5.1 South Africa Smart Inhalers Market by Product
7.4.4.5.2 South Africa Smart Inhalers Market by Disease Indication
7.4.4.5.3 South Africa Smart Inhalers Market by Distribution Channel
7.4.4.6 Nigeria Smart Inhalers Market
7.4.4.6.1 Nigeria Smart Inhalers Market by Product
7.4.4.6.2 Nigeria Smart Inhalers Market by Disease Indication
7.4.4.6.3 Nigeria Smart Inhalers Market by Distribution Channel
7.4.4.7 Rest of LAMEA Smart Inhalers Market
7.4.4.7.1 Rest of LAMEA Smart Inhalers Market by Product
7.4.4.7.2 Rest of LAMEA Smart Inhalers Market by Disease Indication
7.4.4.7.3 Rest of LAMEA Smart Inhalers Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Adherium Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals and Trials:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Teva Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 OPKO Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Aptar Group, Inc. (Cohero Health Inc.)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Novartis AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Approvals and Trials:
8.8 ResMed, Inc. (Propeller Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 Cognita Labs, LLC
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Vectura Group plc (Philip Morris International, Inc.)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses

TABLE 1 Global Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 2 Global Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Smart Inhalers Market
TABLE 4 Product Launches And Product Expansions– Smart Inhalers Market
TABLE 5 Acquisition and Mergers– Smart Inhalers Market
TABLE 6 Approvals and trials- smart inhalers market
TABLE 7 Global Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 8 Global Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 9 Global Metered Dose Inhalers (MDI's) Market by Region, 2017 - 2020, USD Thousands
TABLE 10 Global Metered Dose Inhalers (MDI's) Market by Region, 2021 - 2027, USD Thousands
TABLE 11 Global Dry Powdered Inhalers (DPIs) Market by Region, 2017 - 2020, USD Thousands
TABLE 12 Global Dry Powdered Inhalers (DPIs) Market by Region, 2021 - 2027, USD Thousands
TABLE 13 Global Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 14 Global Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 15 Global Asthma Market by Region, 2017 - 2020, USD Thousands
TABLE 16 Global Asthma Market by Region, 2021 - 2027, USD Thousands
TABLE 17 Global Chronic Obstructive Pulmonary Disease (COPD) Market by Region, 2017 - 2020, USD Thousands
TABLE 18 Global Chronic Obstructive Pulmonary Disease (COPD) Market by Region, 2021 - 2027, USD Thousands
TABLE 19 Global Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 20 Global Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 21 Global Hospitals Pharmacies Market by Region, 2017 - 2020, USD Thousands
TABLE 22 Global Hospitals Pharmacies Market by Region, 2021 - 2027, USD Thousands
TABLE 23 Global Retail Pharmacies Market by Region, 2017 - 2020, USD Thousands
TABLE 24 Global Retail Pharmacies Market by Region, 2021 - 2027, USD Thousands
TABLE 25 Global Online Pharmacies Market by Region, 2017 - 2020, USD Thousands
TABLE 26 Global Online Pharmacies Market by Region, 2021 - 2027, USD Thousands
TABLE 27 Global Smart Inhalers Market by Region, 2017 - 2020, USD Thousands
TABLE 28 Global Smart Inhalers Market by Region, 2021 - 2027, USD Thousands
TABLE 29 North America Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 30 North America Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 31 North America Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 32 North America Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 33 North America Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 34 North America Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 35 North America Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 36 North America Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 37 North America Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 38 North America Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 39 North America Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 40 North America Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 41 North America Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 42 North America Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 43 North America Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 44 North America Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 45 North America Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 46 North America Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 47 North America Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 48 North America Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 49 North America Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 50 North America Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 51 North America Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 52 North America Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 53 US Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 54 US Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 55 US Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 56 US Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 57 US Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 58 US Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 59 US Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 60 US Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 61 Canada Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 62 Canada Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 63 Canada Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 64 Canada Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 65 Canada Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 66 Canada Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 67 Canada Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 68 Canada Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 69 Mexico Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 70 Mexico Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 71 Mexico Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 72 Mexico Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 73 Mexico Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 74 Mexico Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 75 Mexico Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 76 Mexico Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 77 Rest of North America Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 78 Rest of North America Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 79 Rest of North America Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 80 Rest of North America Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 81 Rest of North America Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 82 Rest of North America Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 83 Rest of North America Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 84 Rest of North America Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 85 Europe Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 86 Europe Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 87 Europe Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 88 Europe Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 89 Europe Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 90 Europe Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 91 Europe Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 92 Europe Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 93 Europe Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 94 Europe Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 95 Europe Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 96 Europe Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 97 Europe Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 98 Europe Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 99 Europe Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 100 Europe Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 101 Europe Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 102 Europe Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 103 Europe Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 104 Europe Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 105 Europe Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 106 Europe Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 107 Europe Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 108 Europe Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 109 Germany Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 110 Germany Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 111 Germany Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 112 Germany Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 113 Germany Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 114 Germany Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 115 Germany Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 116 Germany Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 117 UK Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 118 UK Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 119 UK Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 120 UK Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 121 UK Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 122 UK Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 123 UK Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 124 UK Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 125 France Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 126 France Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 127 France Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 128 France Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 129 France Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 130 France Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 131 France Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 132 France Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 133 Russia Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 134 Russia Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 135 Russia Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 136 Russia Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 137 Russia Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 138 Russia Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 139 Russia Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 140 Russia Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 141 Spain Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 142 Spain Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 143 Spain Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 144 Spain Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 145 Spain Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 146 Spain Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 147 Spain Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 148 Spain Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 149 Italy Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 150 Italy Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 151 Italy Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 152 Italy Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 153 Italy Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 154 Italy Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 155 Italy Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 156 Italy Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 157 Rest of Europe Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 158 Rest of Europe Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 159 Rest of Europe Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 160 Rest of Europe Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 161 Rest of Europe Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 162 Rest of Europe Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 163 Rest of Europe Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 164 Rest of Europe Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 165 Asia Pacific Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 166 Asia Pacific Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 167 Asia Pacific Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 168 Asia Pacific Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 169 Asia Pacific Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 170 Asia Pacific Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 171 Asia Pacific Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 172 Asia Pacific Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 173 Asia Pacific Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 174 Asia Pacific Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 175 Asia Pacific Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 176 Asia Pacific Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 177 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 178 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 179 Asia Pacific Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 180 Asia Pacific Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 181 Asia Pacific Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 182 Asia Pacific Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 183 Asia Pacific Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 184 Asia Pacific Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 185 Asia Pacific Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 186 Asia Pacific Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 187 Asia Pacific Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 188 Asia Pacific Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 189 China Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 190 China Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 191 China Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 192 China Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 193 China Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 194 China Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 195 China Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 196 China Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 197 Japan Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 198 Japan Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 199 Japan Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 200 Japan Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 201 Japan Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 202 Japan Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 203 Japan Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 204 Japan Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 205 India Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 206 India Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 207 India Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 208 India Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 209 India Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 210 India Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 211 India Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 212 India Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 213 South Korea Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 214 South Korea Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 215 South Korea Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 216 South Korea Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 217 South Korea Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 218 South Korea Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 219 South Korea Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 220 South Korea Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 221 Singapore Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 222 Singapore Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 223 Singapore Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 224 Singapore Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 225 Singapore Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 226 Singapore Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 227 Singapore Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 228 Singapore Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 229 Malaysia Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 230 Malaysia Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 231 Malaysia Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 232 Malaysia Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 233 Malaysia Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 234 Malaysia Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 235 Malaysia Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 236 Malaysia Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 237 Rest of Asia Pacific Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 238 Rest of Asia Pacific Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 239 Rest of Asia Pacific Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 240 Rest of Asia Pacific Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 241 Rest of Asia Pacific Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 242 Rest of Asia Pacific Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 243 Rest of Asia Pacific Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 244 Rest of Asia Pacific Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 245 LAMEA Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 246 LAMEA Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 247 LAMEA Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 248 LAMEA Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 249 LAMEA Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 250 LAMEA Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 251 LAMEA Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 252 LAMEA Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 253 LAMEA Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 254 LAMEA Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 255 LAMEA Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 256 LAMEA Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 257 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 258 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 259 LAMEA Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 260 LAMEA Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 261 LAMEA Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 262 LAMEA Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 263 LAMEA Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 264 LAMEA Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 265 LAMEA Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 266 LAMEA Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 267 LAMEA Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 268 LAMEA Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 269 Brazil Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 270 Brazil Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 271 Brazil Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 272 Brazil Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 273 Brazil Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 274 Brazil Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 275 Brazil Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 276 Brazil Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 277 Argentina Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 278 Argentina Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 279 Argentina Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 280 Argentina Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 281 Argentina Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 282 Argentina Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 283 Argentina Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 284 Argentina Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 285 UAE Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 286 UAE Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 287 UAE Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 288 UAE Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 289 UAE Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 290 UAE Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 291 UAE Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 292 UAE Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 293 Saudi Arabia Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 294 Saudi Arabia Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 295 Saudi Arabia Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 296 Saudi Arabia Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 297 Saudi Arabia Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 298 Saudi Arabia Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 299 Saudi Arabia Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 300 Saudi Arabia Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 301 South Africa Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 302 South Africa Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 303 South Africa Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 304 South Africa Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 305 South Africa Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 306 South Africa Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 307 South Africa Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 308 South Africa Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 309 Nigeria Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 310 Nigeria Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 311 Nigeria Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 312 Nigeria Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 313 Nigeria Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 314 Nigeria Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 315 Nigeria Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 316 Nigeria Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 317 Rest of LAMEA Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 318 Rest of LAMEA Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 319 Rest of LAMEA Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 320 Rest of LAMEA Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 321 Rest of LAMEA Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 322 Rest of LAMEA Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 323 Rest of LAMEA Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 324 Rest of LAMEA Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 325 Key Information – Adherium Limited
TABLE 326 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 327 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 328 KEY INFORMATION – ASTRAZENECA PLC
TABLE 329 Key Information – OPKO Health, Inc.
TABLE 330 key Information – Aptar Group, Inc.
TABLE 331 Key Information – Novartis AG
TABLE 332 Key Information – ResMed, Inc.
TABLE 333 Key Information – Cognita Labs, LLC
TABLE 334 Key Information – Vectura Group plc

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Global Smart Inhalers Market Share by Product, 2020
FIG 4 Global Smart Inhalers Market Share by Product, 2027
FIG 5 Global Smart Inhalers Market by Product, 2017 - 2027, USD Thousands
FIG 6 Global Smart Inhalers Market Share by Disease Indication, 2020
FIG 7 Global Smart Inhalers Market Share by Disease Indication, 2027
FIG 8 Global Smart Inhalers Market by Disease Indication, 2017 - 2027, USD Thousands
FIG 9 Global Smart Inhalers Market Share by Distribution Channel, 2020
FIG 10 Global Smart Inhalers Market Share by Distribution Channel, 2027
FIG 11 Global Smart Inhalers Market by Distribution Channel, 2017 - 2027, USD Thousands
FIG 12 Global Smart Inhalers Market Share by Region, 2020
FIG 13 Global Smart Inhalers Market Share by Region, 2027
FIG 14 Global Smart Inhalers Market by Region, 2017 - 2027, USD Thousands
FIG 15 Recent strategies and developments: Adherium Limited
FIG 16 Recent strategies and developments: AptarGroup, Inc.